An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV™ test

Sexually Transmitted Infections

Volumn 72, Issue 2, 1996, Pages 132-135

  Borchardt, K A ^a   Li, Z ^a   Zhang, M Z ^a   Shing, H ^b  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

^b City Clinic   (United States)

Author keywords

InPouch TV; Metronidazole; Trichomonas vaginalis

Indexed keywords

METRONIDAZOLE; ANTITRICHOMONAL AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; PRIORITY JOURNAL; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; ANIMAL; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; METHODOLOGY; PARASITOLOGY; TIME;

ANIMALS; ANTITRICHOMONAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; HUMANS; METRONIDAZOLE; PARASITOLOGY; TIME FACTORS; TRICHOMONAS VAGINALIS;

EID: 0029666220     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.72.2.132     Document Type: Article

References (11)

1. Roe FJ. Metronidazole: review of uses and toxicity. J Antimicrob Chemother 1977;3:205-12. (Pubitemid 8097315)
2. Lossick JG, Kent HL. Trichomoniasis: trends in diagnosis and management. Am J Obstet Gynecol 1991;165:1217-22.
3. Markell EK, Voge M, John DT. Trichomonas vaginalis. In: Markell EK, Voge M, John DT, eds. Medical Parasitology, Philadelphia: WB Saunders Company, 7th ed. 1992:72-5.
4. Lossick JG. Therapy of urogenital trichomoniasis. In: Honingerly BM, ed. Trichomonads parasitic in humans, New York: Springer-Verlag 1st ed. 1989:324-41.
5. Yarlett NH, Yarlett NC. Activities of metronidazole and niridazole against Trichomonas vaginalis clinical isolates. J Antimicrob Chemother 1987;19:767-70. (Pubitemid 17092062)
6. Kane PO, McFadzean JA, Squires S. Absorption and excretion of metronidazole. Part II. Studies on primary failures. Br J Venereal Dis 1961;37:276-7.
7. Nicol CS, Evans AJ, McFadzean JA, Squires S. Inactivation of metronidazole. Lancet 1966;6:441.
8. Robertson DH, Heyworth R, Harrison C, Lumsden WH. Treatment failure in Trichomonas vaginalis infections in females. I. Concentrations of metronidazole in plasma and vaginal content during normal and high dosage. J Antimicrob Chemother 1988;21:373-8.
9. Meingassner JG, Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. J Antimicrob Chemother 1978;15:254-7.
10. Smith RF, Di Domenico A. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole. Sex Transm Dis 1980:120-4. (Pubitemid 11214668)
11. Lossick JG, Muller M, Gorrell TE. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J Inf Dis 1986;153:948-55.